Business & regional news

Together with Kings College Hospital, Medtronic has been awarded £2.5 million of government funding for a large-scale, real-world trial of GI Genius in NHS hospitals around the UK. The...

SCAI 2023 Scientific Sessions: Harmony™ Transcatheter Pulmonary Valve System Demonstrates Strong Clinical and Hemodynamic Outcomes at Two Years

Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System

Medtronic Singapore has won the top accolades for three major awards recognizing the best workplace and people practices

Presented at Charing Cross, 10-Year Clinical Data from Global ENGAGE OUS Registry Support Endurant Stent Graft System’s AAA Market-Leading Position Worldwide

Heart failure is a debilitating and progressive disease, tied to substantial patient morbidity and death, and to significant healthcare costs. Cardiac resynchronization therapy (CRT) is a proven...

12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9™ Catheter

MRI Care Pathway can increase flexibility and efficiency with new tools developed to streamline workflow

Medtronic has received the top award in the categories of Patient Advocacy Program of the Year (Philippines) and Hospital Partnership of the Year (Philippines) at the recent Healthcare Asia...

ACC.23/WCC Late-Breaking Clinical Trial: Evolut™ is only TAVR to show excellent outcomes in low-risk patients at 3 years

CRT 2023 Late-Breaking Data: CoreValve/Evolut™ platform demonstrates significantly lower bioprosthetic valve dysfunction compared to surgery at five years

Harmony™ Transcatheter Pulmonary Valve System is the first FDA-approved minimally invasive valve designed for the right side of the heart

Medtronic plc (NYSE: MDT) recently announced the appointment of Michael Blackwell as Vice President of India Medtronic Pvt. Ltd., effective January 2023. In this role, he will be responsible for...

ADVANCE Trial compares sac regression in the Medtronic Endurant™ II/IIs stent graft system and the Gore® Excluder®* AAA Device Family systems

London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, launched the Medtronic Customer eXperience Center (MCXC) in Singapore, leveraging innovative healthcare technologies across extended reality (XR), augmented and virtual realities, and robotics, to connect the global healthcare community from anywhere, at any time.

Late-breaking clinical presentations at VIVA show IN.PACT™ Admiral™ drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting

The MiniMed 780G system is the only insulin pump that automatically adjusts and corrects every five minutes to help keep sugar levels in range Auto-correction algorithm delivers both background...

World Stroke Congress 2022: DiVERT Stroke Study shows significant differences in post-stroke workflow protocols and cardiac monitoring

-- More than two dozen GI GeniusTM intelligent endoscopy modules active across seven MNGI Digestive Health clinics will improve the accuracy of colonoscopies for Minnesotans --

Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients

-- FORTUNE puts Medtronic among top 50 global companies having a positive social impact through core business strategy

-- Veterans will have access to GI Genius™ intelligent endoscopy modules across the country that use AI help to detect colorectal polyps during colonoscopy --

-- Among Veterans, Colorectal cancer is of the five most frequently diagnosed cancers and a leading cause of cancer-related deaths --

-- Nexpowder™* provides gastroenterologists improved visibility, controls upper gastrointestinal (GI) bleeding effectively and with ease^1,2,3 --

-- Nexpowder™* endoscopic hemostasis system showed a lower rebleeding rate and has nearly double the adhesive force of other hemostatic sprays^2,3 --

Medtronic been ranked fifth in the 2022 Best Workplaces in Asia list by Great Place to Work, the global authority on workplace culture. This is a significant improvement of six places from 2021....

Bifurcation using Onyx Frontier DES Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the...

Medtronic announced today that it recently received CE mark for its Radiant™ balloon-expandable covered stent, the first and currently only covered stent indicated for use in ChEVAR with the...

TCT 2022: Late-breaking data from Intrepid™ Pilot Study 3-year follow-up & 1-year follow-up from Transfemoral EFS study demonstrate promising valve performance Medtronic today announced new data...

TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...

TCT 2022: Medtronic Unveils Latest Transcatheter Aortic Valve Replacement Data in Late-Breaking Clinical Science and Presentations

George Murgatroyd, general manager and vice president of Digital Surgery at Medtronic, will join Kimberly Powell, vice president of Healthcare and Life Sciences at NVIDIA, in a fireside chat at NVIDIA

Medtronic plc, a global leader in healthcare technology, announces U.S. Food and Drug Administration (FDA) 510(k) clearance for the RespArray™ patient monitor designed for procedural sedation and medical-surgical units.

Combination of InPen™ smart insulin pen system integrated with Guardian™ 4 CGM helps people with diabetes on multiple daily injections (MDI) stay ahead of their glucose levels^i,ii

Partnership enables Patient Monitoring business’ commitment to transforming health monitoring by expanding access to continuous vital sign monitoring of patients from in-hospital to home

Medtronic announced today that it has launched its newest drug-eluting coronary stent, the Onyx Frontier™ drug-eluting stent (DES), following recent CE Mark approval. The Onyx Frontier DES...

Actress Jennifer Stone, best known for her role on the Disney Channel’s “Wizards of Waverly Place”, will be partnering with Medtronic Diabetes to help others living with type 1 diabetes learn more about advanced technologies that can help make life with diabetes easier...

BRAMPTON, July 20, 2022 – Medtronic Canada today announced that Neil Fraser has decided to retire as President of Medtronic Canada ULC and Regional Vice-President, Medtronic plc, effective July...

The Medtronic Foundation launched 10 partnerships with leading equity-based STEM organizations serving students in Southern California, Colorado, and Ireland. Partnerships will remove barriers to quality Science, Technology, Engineering, and Math (STEM) education and create opportunity for economic advancement.